Summary
41 / 100 · Bulios Score
What speaks for it
- The price moves less than the market (beta 0.09).
What to watch
- Earnings per share fell by 71% a year over the last 3 years.
- It passes only 1 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
There is not enough revenue history yet to say how fast it grows. Earnings per share fell by 71% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash. The debt score is high even though free cash flow is negative.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2023By product
- Principal Transactions 100%
By region
The company reports no revenue by region.
Principal Transactions brings in 100% of revenue.
Segments in detail